---
title: "Avanos Medical, Inc. (AVNS.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/AVNS.US.md"
symbol: "AVNS.US"
name: "Avanos Medical, Inc."
industry: "Health Care Supplies"
datetime: "2026-05-20T08:34:44.909Z"
locales:
  - [en](https://longbridge.com/en/quote/AVNS.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AVNS.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AVNS.US.md)
---

# Avanos Medical, Inc. (AVNS.US)

## Company Overview

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | US Market |
| Website | [avanos.com](https://avanos.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:16.000Z

**Overall: C (0.47)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 19 / 45 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 3.87% |  |
| Net Profit YoY | 80.66% |  |
| P/B Ratio | 1.48 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1155185757.00 |  |
| Revenue | 715900000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -9.18% | D |
| Profit Margin | -10.39% | D |
| Gross Margin | 51.70% | B |
| Revenue YoY | 3.87% | C |
| Net Profit YoY | 80.66% | A |
| Total Assets YoY | -5.21% | D |
| Net Assets YoY | -6.83% | D |
| Cash Flow Margin | -49.33% | E |
| OCF YoY | 3.87% | C |
| Turnover | 0.66 | B |
| Gearing Ratio | 25.52% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Avanos Medical, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "3.87%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "80.66%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.48",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "1155185757.00",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "715900000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-9.18%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-10.39%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "51.70%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "3.87%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "80.66%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "-5.21%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-6.83%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-49.33%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "3.87%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.66",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "25.52%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -15.53 | 40/45 | - | - | - |
| PB | 1.48 | 22/45 | 0.83 | 0.70 | 0.67 |
| PS (TTM) | 1.61 | 16/45 | 0.92 | 0.81 | 0.76 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Essilor (ESLOY.US) | B | B | C | B | B | B |
| 02 | HOYA Corporation (HOCPY.US) | A | C | B | A | B | B |
| 03 | Align (ALGN.US) | B | C | B | B | C | B |
| 04 | Lantheus (LNTH.US) | A | C | B | C | C | B |
| 05 | Merit Medical (MMSI.US) | B | B | B | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-14T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Hold | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 24.75 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/AVNS.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/AVNS.US/norm.md)
- [Related News](https://longbridge.com/en/quote/AVNS.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/AVNS.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**